Dogwood Therapeutics Inc.

NASDAQ: DWTX · Real-Time Price · USD
4.82
-0.08 (-1.63%)
At close: Sep 18, 2025, 3:59 PM
4.81
-0.12%
After-hours: Sep 18, 2025, 04:00 PM EDT

Dogwood Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
12.18K n/a n/a n/a
Gross Profit
-12.18K n/a n/a n/a
Operating Income
-12.23M -5.45M -12.32M -15.64M
Interest Income
n/a 150.9K 67.47K 5.67K
Pretax Income
-12.35M -5.3M -12.25M -15.96M
Net Income
-12.35M -5.3M -12.25M -15.96M
Selling & General & Admin
8.7M 3.72M 4.25M 4.85M
Research & Development
3.53M 1.73M 8.07M 10.8M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
12.23M 5.45M 12.32M 15.64M
Interest Expense
92.19K n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
12.23M 5.45M 12.32M 15.64M
Income Tax Expense
-503 n/a n/a n/a
Shares Outstanding (Basic)
1.03M 751.07K 442.8K 333.17K
Shares Outstanding (Diluted)
1.03M 751.07K 442.8K 333.17K
EPS (Basic)
-12.52 -7.05 -27.66 -47.9
EPS (Diluted)
-12.52 -7.05 -27.66 -47.9
EBITDA
-12.25M -5.45M -12.32M -15.64M
EBIT
-12.26M -5.45M -12.32M -15.64M
Depreciation & Amortization
12.18K n/a n/a n/a